GGrantIndex
Sort

11,323 grants matching glioblastoma

Requirements for generation and maintenance of gliomas

$352,663
Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · CA

Enhancing glioma chemotherapy by suppressing Notch signaling

$352,647
Alonzo H Ross · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · NS

Enhancing glioma chemotherapy by suppressing Notch signaling

$352,647
Alonzo H Ross · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · NS

FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS.

$352,621
Tenaci-T Therapeutics Llc · N43 · FY2025 · CA

Glioma Immunotherapy Usingengineered T-Cells

$352,600
City Of Hope/Beckman Research Institute · R01 · FY2005 · CA

Glioma Immunotherapy Using engineered T-Cells

$352,600
City Of Hope/Beckman Research Institute · R01 · FY2004 · CA

Bone marrow derived neural stem cell therapy for glioma

$352,527
John S Yu · Cedars-Sinai Medical Center · R01 · FY2013 · NS

Project 4: Targeting 4EBP1 in glioblastoma

$352,500
William A Weiss · University Of California, San Francisco · P50 · FY2020 · CA

Rapamycin as a potential treatment for succinate dehydrogenase deficiency

$352,428
Eugenia Villa Cuesta · Adelphi University · R15 · FY2021 · GM

Project-002

$352,366
Stuart A Lipton · Scintillon Institute For Photobiology · P30 · FY2016 · NS

Project 1: Sex-specific developmental epigenetics in gliomagenesis

$352,310
Joshua B Rubin · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA

Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology

$352,275
Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2020 · CA

Mechanism-based drug repurposing and novel treatments for glioblastoma

$352,275
Mark D Noble · University Of Rochester · R01 · FY2021 · CA

Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention

$352,275
Michael A Caligiuri · Ohio State University · R01 · FY2017 · CA

Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology

$352,275
Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2018 · CA

Mechanism-based drug repurposing and novel treatments for glioblastoma

$352,275
Mark D Noble · University Of Rochester · R01 · FY2018 · CA

Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention

$352,275
Michael A Caligiuri · Ohio State University · R01 · FY2015 · CA

Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention

$352,275
Michael A Caligiuri · Ohio State University · R01 · FY2016 · CA

Mechanism-based drug repurposing and novel treatments for glioblastoma

$352,275
Mark D Noble · University Of Rochester · R01 · FY2020 · CA

Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology

$352,275
Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2021 · CA

Circulating Cell-Free DNA as a Personalized Biomarker to Diagnose and Monitor Glioblastoma Extension

$352,227
Hunter Reeve Underhill · Utah State Higher Education System--University Of Utah · R37 · FY2025 · CA

Project 3: Inhibition of radiation-induced phenotype conversion in glioblastoma

$352,182
Frank Pajonk · University Of California Los Angeles · P50 · FY2017 · CA

Understanding Mechanisms of Resistance to Anti-angiogenic Treatments

$352,126
Ali Syed Arbab · Augusta University · R01 · FY2014 · CA

Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors

$352,049
Jing Li · Wayne State University · R01 · FY2024 · CA

Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants

$352,047
Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA